Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001689375-24-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | TRDA | KIM PETER S | Dir | M - OptEx | $6.06 | +11.9K | 104.3K | +13% | +$72.2K |
| D | 2024-06-05 | 2024-06-03 | TRDA | KIM PETER S | Dir | M - OptEx | $0.00 | -11.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | M | A | 11,918 | $6.06 | 104,330 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-03 | M | D | 11,918 | $0.00 | 0 | D | $6.06 · — to 2032-06-02 | 11,918 Common Stock | (F1) The shares subject to this option fully vested on June 2, 2023. |